- Amgen: Daiwa Securities downgrades to neutral from outperform. PT up 3% to $220
- Apple: Tigress Financial raises Apple PT to $198 from $182, maintains Strong Buy rating
- AstraZeneca: Credit Suisse retains its positive opinion on the stock with a Buy rating. The target price remains unchanged at GBp 9000.
- AvalonBay: Goldman Sachs reinstated coverage with a recommendation of buy. PT raised 15% to $257
- Brookfield Renewable Partners: Raymond James upgrades to Outperform from Market Perform, adjusts PT to $44 from $41
- Camden Property: Goldman Sachs reinstated coverage with a recommendation of buy. PT up 14% to $172
- Discovery : UBS adjusts price target on discovery to $27 from $38, maintains neutral rating
- Equity Residential: Goldman Sachs reinstated coverage with a recommendation of neutral. PT up 5.7% to $86
- FedEx : UBS adjusts price target on fedex to $369 from $380, maintains buy rating
- InnovAge : Goldman Sachs adjusts PT to $17 From $28, maintains Buy rating
- Mid-America: Goldman Sachs reinstated coverage with a recommendation of neutral. PT up 6.2% to $202
- Pentair: Oppenheimer adjusts PT to $84 From $80, maintains Outperform rating
- Raymond James Financial : Morgan Stanley adjusts Price Target to $66.67 from $100, maintains Overweight rating
- Rolls-Royce: Berenberg has maintained his recommendation on the stock with a Buy rating. The target price is reviewed upwards from GBp 150 to GBp 160.
- T-Mobile U.S.: Goldman Sachs retains its positive opinion on the stock with a Buy rating. The target price remains unchanged at USD 160.
- Trimble: Morgan Stanley downgrades to underweight from equal-weight. PT down 18% to $74
- UDR: Goldman Sachs reinstated coverage with a recommendation of buy. PT raised 12% to $60
- Vodafone: Goldman Sachs keeps its Buy rating on the stock. The target price is still set at GBp 180.